Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today.
Reported sales increased 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion while EPS fell 34% to $1.11 compared to last year. Adjusted EPS was down 9% to $2.42.
Revenue and earnings beat expectations.
For full-year 2024, JNJ expects reported sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
The stock was down 1% in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
MU Earnings: Micron Q2 profit jumps on higher revenues, tops expectations
Semiconductor company Micron Technology Inc. (NASDAQ: MU) Thursday reported a sharp increase in revenues and earnings for the second quarter of 2025. Earnings also surpassed Wall Street's forecasts. The Idaho-headquartered
Darden Restaurants sees growth in FY25 and beyond amid menu, tech Innovations
Darden Restaurants, Inc. (NYSE: DRI) has successfully navigated the challenging market environment by constantly innovating its menu offerings and fostering customer loyalty. In the third quarter, sales and profit margin
What to look for when McCormick & Company (MKC) reports Q1 2025 earnings
Shares of McCormick & Company, Incorporated (NYSE: MKC) were down 1% on Thursday. The stock has gained 5% year-to-date. The spice giant is slated to report its first quarter 2025 earnings results
